http://rdf.ncbi.nlm.nih.gov/pubchem/patent/GB-1283810-A
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_cab64dfbe7ad218bda5bdcddbc2bf326 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_878b3d36a04be157c32775fb2f3f3240 |
| filingDate | 1970-12-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a959013ec5eddec88f2dfee88e529d45 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ff996d277337a6c35def920bca2706ae |
| publicationDate | 1972-08-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | GB-1283810-A |
| titleOfInvention | Magnesium aspartate hydrohalides |
| abstract | 1283810 Magnesium aspartate hydrohalides H J V EHRLICH [trading as VERLAPHARM ARZNEIMITTEL-FABRIK] 30 Dec 1970 61705/70 Heading C2C Novel compounds of formula wherein Hal represents F, Cl, Br or I, are prepared by reacting a solution of magnesium diaspartate with the hydrohalic acid. Pharmaceutical compositions in conventional forms comprise an above novel salt and a carrier and are useful as sedatives and tranquillizers and in the treatment of thyrotoxicosis and magnesium deficiency for example, as a prophylactic against caries. |
| isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/FR-2660653-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0108937-A2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-9115463-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0108937-A3 |
| priorityDate | 1970-12-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 19.